Charlotta Karner

1.7k total citations
29 papers, 1.0k citations indexed

About

Charlotta Karner is a scholar working on Pulmonary and Respiratory Medicine, Physiology and Molecular Biology. According to data from OpenAlex, Charlotta Karner has authored 29 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Pulmonary and Respiratory Medicine, 13 papers in Physiology and 5 papers in Molecular Biology. Recurrent topics in Charlotta Karner's work include Asthma and respiratory diseases (13 papers), Respiratory Support and Mechanisms (7 papers) and Chronic Obstructive Pulmonary Disease (COPD) Research (7 papers). Charlotta Karner is often cited by papers focused on Asthma and respiratory diseases (13 papers), Respiratory Support and Mechanisms (7 papers) and Chronic Obstructive Pulmonary Disease (COPD) Research (7 papers). Charlotta Karner collaborates with scholars based in United Kingdom, New Zealand and Australia. Charlotta Karner's co-authors include Jimmy Chong, Phillippa Poole, Christopher J Cates, Steven J Edwards, Kayleigh M Kew, Sally Spencer, Katharina Mahn, Stuart J. Hirst, David E. Simcock and Brian O’Connor and has published in prestigious journals such as Proceedings of the National Academy of Sciences, SHILAP Revista de lepidopterología and American Journal of Respiratory and Critical Care Medicine.

In The Last Decade

Charlotta Karner

26 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Charlotta Karner United Kingdom 19 650 566 139 91 75 29 1.0k
Sy Duong‐Quy Vietnam 18 592 0.9× 408 0.7× 106 0.8× 90 1.0× 11 0.1× 97 985
Rui Zhu China 16 202 0.3× 406 0.7× 165 1.2× 41 0.5× 24 0.3× 52 1.2k
Ronald Olivenstein Canada 20 1.1k 1.7× 1.5k 2.7× 179 1.3× 58 0.6× 29 0.4× 43 1.9k
Emma Hilton United Kingdom 18 390 0.6× 323 0.6× 325 2.3× 44 0.5× 33 0.4× 40 1.1k
Alexis Rames United States 12 259 0.4× 401 0.7× 73 0.5× 27 0.3× 5 0.1× 16 714
Lin Ying Liu United States 15 234 0.4× 703 1.2× 109 0.8× 35 0.4× 9 0.1× 16 1.1k
Antonio Castagnaro Italy 13 470 0.7× 426 0.8× 71 0.5× 22 0.2× 4 0.1× 16 714
Jessica González Spain 13 173 0.3× 79 0.1× 74 0.5× 29 0.3× 18 0.2× 46 495
Dean Quinn New Zealand 11 273 0.4× 403 0.7× 154 1.1× 101 1.1× 3 0.0× 20 789
Fabrizio Facchini Italy 9 716 1.1× 655 1.2× 69 0.5× 59 0.6× 7 0.1× 13 1.0k

Countries citing papers authored by Charlotta Karner

Since Specialization
Citations

This map shows the geographic impact of Charlotta Karner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Charlotta Karner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Charlotta Karner more than expected).

Fields of papers citing papers by Charlotta Karner

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Charlotta Karner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Charlotta Karner. The network helps show where Charlotta Karner may publish in the future.

Co-authorship network of co-authors of Charlotta Karner

This figure shows the co-authorship network connecting the top 25 collaborators of Charlotta Karner. A scholar is included among the top collaborators of Charlotta Karner based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Charlotta Karner. Charlotta Karner is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Edwards, Steven J, et al.. (2024). Abrocitinib, tralokinumab and upadacitinib for treating moderate-to-severe atopic dermatitis.. SHILAP Revista de lepidopterología. 28(4). 1–113. 9 indexed citations
2.
Karner, Charlotta, et al.. (2019). Targeted therapies for previously treated advanced or metastatic renal cell carcinoma: systematic review and network meta-analysis. BMJ Open. 9(3). e024691–e024691. 14 indexed citations
3.
Edwards, Steven J, et al.. (2017). Diagnostic accuracy of reflectance confocal microscopy using VivaScope for detecting and monitoring skin lesions: a systematic review. Clinical and Experimental Dermatology. 42(3). 266–275. 28 indexed citations
4.
Barton, Samantha, et al.. (2016). Clinical effectiveness and cost-effectiveness of interventions for the treatment of anogenital warts: systematic review and economic evaluation. Health Technology Assessment. 20(24). 1–486. 35 indexed citations
5.
Cates, Christopher J & Charlotta Karner. (2015). Clinical importance cannot be ruled out using mean difference alone. BMJ. 351(nov20 4). h5496–h5496. 15 indexed citations
6.
7.
Welsh, Emma J, Elizabeth Stovold, Charlotta Karner, & Christopher J Cates. (2014). Cochrane Airways Group reviews were prioritized for updating using a pragmatic approach. Journal of Clinical Epidemiology. 68(3). 341–346. 13 indexed citations
8.
Karner, Charlotta, Jimmy Chong, & Phillippa Poole. (2014). Tiotropium versus placebo for chronic obstructive pulmonary disease. Cochrane Database of Systematic Reviews. 2016(11). CD009285–CD009285. 147 indexed citations
9.
Cates, Christopher J & Charlotta Karner. (2013). Combination formoterol and budesonide as maintenance and reliever therapy versus current best practice (including inhaled steroid maintenance), for chronic asthma in adults and children. Cochrane Database of Systematic Reviews. 2016(7). CD007313–CD007313. 58 indexed citations
10.
11.
Edwards, Sophie, et al.. (2013). Comparisons of the Clinical Effectiveness of Treatments for the Symptoms Associated with Overactive Bladder (OAB). Value in Health. 16(7). A630–A630. 1 indexed citations
12.
Karner, Charlotta, Jimmy Chong, & Phillippa Poole. (2012). Tiotropium versus placebo for chronic obstructive pulmonary disease. Cochrane Database of Systematic Reviews. CD009285–CD009285. 63 indexed citations
13.
Chong, Jimmy, Charlotta Karner, & Phillippa Poole. (2012). Tiotropium versus long-acting beta-agonists for stable chronic obstructive pulmonary disease. Cochrane Database of Systematic Reviews. 2016(11). CD009157–CD009157. 74 indexed citations
14.
Karner, Charlotta, et al.. (2012). Primary care based clinics for asthma. Cochrane Database of Systematic Reviews. 2012(4). CD003533–CD003533. 22 indexed citations
15.
Karner, Charlotta & Christopher J Cates. (2011). The effect of adding inhaled corticosteroids to tiotropium and long-acting beta 2 -agonists for chronic obstructive pulmonary disease. Cochrane Database of Systematic Reviews. 2013(5). CD009039–CD009039. 25 indexed citations
16.
Spencer, Sally, Charlotta Karner, Christopher J Cates, & David Evans. (2011). Inhaled corticosteroids versus long-acting beta2-agonists for chronic obstructive pulmonary disease. Cochrane Database of Systematic Reviews. CD007033–CD007033. 49 indexed citations
17.
Spencer, Sally, David J Evans, Charlotta Karner, & Christopher J Cates. (2011). Inhaled corticosteroids versus long-acting beta2-agonists for chronic obstructive pulmonary disease. Cochrane Database of Systematic Reviews. CD007033–CD007033. 23 indexed citations
18.
Simcock, David E., Varsha Kanabar, Graham W. Clarke, et al.. (2008). Induction of Angiogenesis by Airway Smooth Muscle From Patients with Asthma. American Journal of Respiratory and Critical Care Medicine. 178(5). 460–468. 64 indexed citations
19.
Perez‐Zoghbi, Jose F., et al.. (2008). Ion channel regulation of intracellular calcium and airway smooth muscle function. Pulmonary Pharmacology & Therapeutics. 22(5). 388–397. 78 indexed citations
20.
Page, Clive, David E. Simcock, Charlotta Karner, et al.. (2008). Heparin and structurally related polymers attenuate eotaxin‐1 (CCL11) release from human airway smooth muscle. British Journal of Pharmacology. 154(4). 833–842. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Sy Duong‐Quy Breakdown of academic impact, for papers by Rui Zhu Breakdown of academic impact, for papers by Ronald Olivenstein Breakdown of academic impact, for papers by Emma Hilton Breakdown of academic impact, for papers by Alexis Rames Breakdown of academic impact, for papers by Lin Ying Liu Breakdown of academic impact, for papers by Antonio Castagnaro Breakdown of academic impact, for papers by Jessica González Breakdown of academic impact, for papers by Dean Quinn Breakdown of academic impact, for papers by Fabrizio Facchini
Rankless by CCL
2026